Anavex Life Sciences

(NASDAQ) AVXL

Current Price$2.82

Market Cap$245.12M

Since IPO (2006)+3,867%

5 Year-79%

1 Year-63%

1 Month-16%

Anavex Life Sciences Financials at a Glance

Market Cap

$245.12M

Revenue (TTM)

$0.00

Net Income (TTM)

-$39.95M

EPS (TTM)

-$0.46

P/E Ratio

-5.69

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$2.82

Volume

937,735.88

Open

$2.68

Price

$2.82

Volume

937,735.88

Open

$2.68

Previous Close

$2.82

Daily Range

$2.65 - $2.91

52-Week Range

$2.61 - $13.99

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$2.82

Volume

937,735.88

Open

$2.68

Previous Close

$2.82

Daily Range

$2.65 - $2.91

52-Week Range

$2.61 - $13.99

Estimated Earnings Date

Aug 11, 2026

AVXL News

Page 1

AVXL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anavex Life Sciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Christopher U. Missling, PhD, MBA

Website

www.anavex.com

Headquarters

New York City, NY 10019, US

AVXL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-34%

Return on Capital

-35%

Return on Assets

-30%

Earnings Yield

-17.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$245.12M

Shares Outstanding

92.67M

Volume

937.74K

Avg. Volume

1.38M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$51.41M

EBITDA

-$46.38M

Operating Cash Flow

-$39.04M

Capital Expenditure

$0.00

Free Cash Flow

-$39.04M

Cash & ST Invst.

$102.58M

Total Debt

$0.00

Anavex Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$245.12M

N/A

Market Cap/Employee

$5.84M

N/A

Employees

N/A

Net Income

-$5.68M

+53.1%

EBITDA

-$6.78M

+50.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$131.75M

+9.1%

Accounts Receivable

$844.00K

-67.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-30.04%

N/A

Return on Invested Capital

-35.22%

N/A

Free Cash Flow

-$7.15M

+41.0%

Operating Cash Flow

-$7.15M

+41.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RGNXREGENXBIO Inc.

RGNXREGENXBIO Inc.$6.88+2.84%

ARVNArvinas, Inc.

ARVNArvinas, Inc.$7.74+0.52%

VALNValneva SE

VALNValneva SE$5.67+1.61%

CTMXCytomX Therapeutics, Inc.

CTMXCytomX Therapeutics, Inc.$3.18-1.24%

MGTXMeiraGTx Holdings plc

MGTXMeiraGTx Holdings plc$9.57+1.92%

MBXMBX Biosciences, Inc. Common Stock

MBXMBX Biosciences, Inc. Common Stock$30.91+2.86%

ABSIAbsci Corporation

ABSIAbsci Corporation$7.34+23.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$16.62-0.01%

STISolidion Technology

STISolidion Technology$22.71+3.51%

FOXXFoxx Development

FOXXFoxx Development$5.25+0.84%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$36.02-0.03%

NUNu Holdings

NUNu Holdings$12.12+0.04%

SOFISoFi Technologies

SOFISoFi Technologies$17.15+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.76+0.02%

Questions About AVXL

What is the current price of Anavex Life Sciences?

Anavex Life Sciences is trading at $2.82 per share.

What is the 52-week range for Anavex Life Sciences?

Over the past 52 weeks, Anavex Life Sciences has traded between $2.61 and $13.99.

How much debt does Anavex Life Sciences have?

As of the most recent reporting period, Anavex Life Sciences reported total debt of $0.00.

How much cash does Anavex Life Sciences have on hand?

Anavex Life Sciences reported $131.75M in cash and cash equivalents in its most recent financial results.

What is Anavex Life Sciences’s dividend yield?

Anavex Life Sciences does not currently have a dividend yield.

Anavex Life Sciences

Anavex Life Sciences Financials at a Glance

AVXL News

Wall Street Thinks This Small-Cap Stock Can Quadruple in Value

Why Shares of Anavex Life Sciences Rose 12.4% in February

Is Anavex Life Sciences Stock a Buy Now?

This Short-Squeeze Candidate Could Actually Pan Out in the Long Run

Why Anavex Life Sciences Stock Bolted Higher in January

Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why

Is Anavex Life Sciences a Buy?

Is Anavex Life Sciences a Smart Stock to Buy Now?

AVXL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Anavex Life Sciences

AVXL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Anavex Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AVXL

What is the current price of Anavex Life Sciences?

What is the 52-week range for Anavex Life Sciences?

How much debt does Anavex Life Sciences have?

How much cash does Anavex Life Sciences have on hand?

What is Anavex Life Sciences’s dividend yield?

Premium Investing Services